Gene: IRGQ
Official Full Name: immunity related GTPase Qprovided by HGNC
Gene Summary: Predicted to enable GTP binding activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27384 | IRGQ Knockout cell line (HeLa) | Human | IRGQ | 1:3~1:6 | Negative | Online Inquiry |
KO27385 | IRGQ Knockout cell line (HCT 116) | Human | IRGQ | 1:2~1:4 | Negative | Online Inquiry |
KO27386 | IRGQ Knockout cell line (HEK293) | Human | IRGQ | 1:3~1:6 | Negative | Online Inquiry |
KO27387 | IRGQ Knockout cell line (A549) | Human | IRGQ | 1:3~1:4 | Negative | Online Inquiry |
IRGQ Gene Knockout Cell Lines are highly specialized cellular models designed for researchers studying the roles of the IRGQ gene in various biological processes and diseases. These knockout cell lines are generated using advanced CRISPR/Cas9 technology, which allows for precise editing of the genomic DNA. By specifically disrupting the IRGQ gene, these models facilitate the investigation of gene function and associated pathways, making them invaluable tools in molecular biology and genetics research.
The key function of IRGQ Gene Knockout Cell Lines lies in their ability to elucidate the biological consequences of IRGQ gene inactivation. Researchers can utilize these cell lines to assess cellular phenotypes, signaling pathways, and the impact of IRGQ on processes such as immune responses, apoptosis, and cell proliferation. The mechanistic insights gained from these studies can further enhance understanding in areas like cancer research, autoimmune diseases, and infectious diseases where IRGQ may play a critical role.
In clinical and research settings, these knockout cell lines offer significant advantages over traditional models, including speed of generation and the ability to create isogenic cell lines that minimize genetic variability. This specificity allows for reproducibility and consistency in experimental results, which are crucial for validating hypotheses and developing therapeutic strategies.
Additionally, researchers benefit from the flexibility of these cell lines, which can be adapted for high-throughput screening or further modified to study drug interactions and gene therapy approaches. The precision of knockout models also helps in reducing off-target effects, increasing the reliability of experimental outcomes.
Our company is recognized for its expertise in genetic engineering and cell line development, ensuring that every product, including the IRGQ Gene Knockout Cell Lines, is rigorously validated and tailored to meet the specific needs of researchers and clinicians. By choosing our products, you gain access to cutting-edge tools that can significantly advance your research and enhance your understanding of complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.